Consistent with findings from the pilot cohort, protein levels of both soluble and insoluble UFM1, as well as insoluble UFSP2, were all significantly increased in both brain regions from the larger AD group compared to controls as measured by MSD ELISA. Here, UFM1 is linked to Alzheimer disease.